Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multi-Antiviral Resistance”

13 trials

Showing 13 of 13 results

Testing effectiveness (Phase 2)Study completedNCT00895596
What this trial is testing

Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
LG Life Sciences 65
Large-scale testing (Phase 3)Study completedNCT02792088
What this trial is testing

Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside Analogues

Who this might be right for
Chronic Hepatitis B
IlDong Pharmaceutical Co Ltd 146
Early research (Phase 1)Study completedNCT01473056
What this trial is testing

Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected Subjects

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy of
Akros Pharma Inc. 29
Post-approval studies (Phase 4)UnknownNCT01594905
What this trial is testing

Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic Hepatitis B
Yonsei University 90
Early research (Phase 1)Study completedNCT01181427
What this trial is testing

Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

Who this might be right for
HCV Infection
Abbott 137
Large-scale testing (Phase 3)Study completedNCT00002220
What this trial is testing

Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 120
Not applicableStudy completedNCT03127358
What this trial is testing

Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs

Who this might be right for
Hepatitis CMedication Adherence
Albert Einstein College of Medicine 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT04648280
What this trial is testing

Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance

Who this might be right for
HIV Infections With Multi Drug Resistant Virus
PENTA Foundation 60
Testing effectiveness (Phase 2)Study completedNCT00964327
What this trial is testing

TMC114-C201: A Study to Determine the Antiviral Activity of TMC114 in Patients With Multiple Protease Inhibitor (PI) Resistant Human Immunodeficiency Virus (HIV) Strains

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland 42
Not applicableStudy completedNCT02824640
What this trial is testing

Patient-Centered Models of HCV Care for People Who Inject Drugs

Who this might be right for
Hepatitis CMedication Adherence
Prisma Health-Upstate 755
Not applicableActive Not RecruitingNCT05388474
What this trial is testing

A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

Who this might be right for
HIV InfectionsMulti-Antiviral Resistance
Theratechnologies 168
Testing effectiveness (Phase 2)UnknownNCT00299897
What this trial is testing

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

Who this might be right for
HIV InfectionsHuman Immunodeficiency Virus
Samaritan Pharmaceuticals, Inc 60
Not applicableLooking for participantsNCT04098315
What this trial is testing

Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease.

Who this might be right for
HIV-1-infectionMulti-Antiviral Resistance
Castagna Antonella 300

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation